Entereg helps restore bowel function in hospitalized patients - - Drug Topics

ADVERTISEMENT

Entereg helps restore bowel function in hospitalized patients


Drug Topics E-News

Hospital pharmacists will soon have a new drug they have to get trained on. It’s Entereg (alvimopan), designed to restore bowel function in adults who have undergone abdominal surgery and are on pain medication. Offered by Adolor Corp. and GlaxoSmithKline, the peripherally acting mu-opioid receptor has strict requirements that users must meet. Only hospitals that are certified can dispense the product, which should only be used for inpatients for the short term.

To see more Daily News articles, click here.

To go to the Drug Topics homepage, click here.

 

Drug Topics Issue
Drug Topics is a monthly news magazine, guided by a board of pharmacy leaders, reporting on all phases of community, retail, and health-system issues and trends. We cover managed care and professional, national, and state activities as well as new therapies involving prescription and OTC drugs.
ARCHIVES | RSS | E-NEWS | DIGITAL EDITION

ADVERTISEMENT

ADVERTISEMENT

Survey
How do you deal with the physically stressful side of work in the pharmacy (e.g., being on your feet for 12 hours a day, cradling the telephone handset between your shoulder and neck, etc.)?
I receive chiropractic/massotherapy/acupuncture/etc. as needed
I am receiving physical therapy
I have had some form of surgery
I have no physical problems connected with work
Denial is working well for me
I receive chiropractic/massotherapy/acupuncture/etc. as needed
28%
I am receiving physical therapy
6%
I have had some form of surgery
9%
I have no physical problems connected with work
19%
Denial is working well for me
37%
View Results

Modern Medicine logoDrug Topics archives are now available on ModernMedicine.com, a new online resource designed to meet the evolving needs of physicians.
Register now (it's free and quick) or Find out more.

Keep visiting Drug Topics for fresh content, news, opinions, editor's blogs and more.

ADVERTISEMENT

Source: Drug Topics E-News,
Click here